51
Participants
Start Date
January 18, 2023
Primary Completion Date
September 30, 2029
Study Completion Date
September 30, 2029
ARGX-117
Intravenous administration of ARGX-117
Placebo
Intravenous administration of placebo
Medizinische Universitat Wien (Medical University of Vienna), Vienna
AZ Sint-Lucas, Ghent
University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
IRCCS Humanitas Research Hospital, Rozzano
IRCCS Ospedale San Raffaele S.r.l., Milan
CHU Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux
Universitatsmedizin Gottingen (UMG) Georg-August-Universitaet, Göttingen
The Cleveland Clinic Foundation, Cleveland
Universitätsklinikum Essen, Essen
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
University of Minnesota, Minneapolis
Azienda Ospedaliero Universitaria Pisana, Pisa
Hôpital Roger Salengro (CHU de Lille), Lille
NorthShore University HealthSystem, Glenview
Hôpital de la Pitié Salpétrière, Paris
Austin Neuromuscular Center, Austin
HonorHealth Neurology, Scottsdale
University Health Network, Toronto
CHU de Nice, Nice
Azienda Ospedaliera Sant' Andrea, Rome
Universitair Medisch Centrum Utrecht, Utrecht
Michalski i Partnerzy Lekarze Spolka Partnerska, Krakow
Warszawski Uniwersytet Medyczny, Warsaw
Hospital Universitario Vall d'Hebron, Barcelona
Hospital de La Santa Creu i Sant Pau, Barcelona
Queen Elizabeth University Hospital, Glasgow
Oxford University Hospitals NHS Trust, Oxford
Lead Sponsor
argenx
INDUSTRY